Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibodyXiaojie Yu, Bohua Li, Huajing Wang et al.|Molecular Immunology|2017Cited by 23
Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibodyChao Wang, Bohua Li, Huajing Wang et al.|Oncotarget|2017Cited by 21
An anti-ErbB2 fully human antibody circumvents trastuzumab resistanceQiong Lu, Bohua Li, Chao Wang et al.|Oncotarget|2016Cited by 15